Grand Yangtze Capital
Shanghaigrandyangtze.com
Overview
Grand Yangtze Capital is a Shanghai-based venture capital and private equity firm that focuses on investments in early, growth, and expansion stage enterprises in China across sectors including consumer goods, technology, healthcare, and manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eaglenos Sciences, Inc. | May 2023 | Series A | Lead |
| Shanghai Medium Bank Biotechnology | Nov 2020 | Early Funding | Co-investor |
| InxMed Limited | Sep 2020 | Series A Extension | Co-investor |
| Bubi (Beijing) Network Technologies Co., Ltd. | Nov 2017 | Series A | Co-investor |
| Beijing PeerSafe Technology Co., Ltd. | Nov 2017 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
